Russell Investments Group
TNYA icon

Russell Investments Group’s Tenaya Therapeutics TNYA Stock Holding History

Russell Investments Group’s Portfolio TNYA Stock Details TNYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,617
Closed -$5.01K – 3796
2024
Q2 		$5.01K Buy
+1,617
New +$6.68K ﹤0.01% 3209
2023
Q4 		– Sell
-19,300
Closed -$49.2K – 3306
2023
Q3 		$49.2K Buy
+19,300
New +$80.8K ﹤0.01% 2756
2023
Q2 		– Sell
-27,488
Closed -$78.3K – 3528
2023
Q1 		$78.3K Buy
+27,488
New +$77.2K ﹤0.01% 2635

Other funds holding TNYA

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
IHAM
Integral Health Asset Management New York $2.09B AUM 112.84% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

Russell Investments Group's TNYA Position: Q3 2024 in Review

Russell Investments Group sold out of Tenaya Therapeutics (TNYA) in Q3 2024, closing a stake of 1,617 shares — an estimated $5.01K sold.

Russell Investments Group first reported a position in TNYA in Q1 2023 and held it in 3 quarters. The position peaked at $78.3K in Q1 2023. 95 funds tracked by Wall St. Rank hold TNYA as of Q3 2024.

  • Russell Investments Group reported no remaining Tenaya Therapeutics position as of Q3 2024 after selling out during the quarter.
  • Russell Investments Group sold 1,617 Tenaya Therapeutics shares in Q3 2024, an estimated $5.01K.
  • Russell Investments Group first reported a position in Tenaya Therapeutics in Q1 2023 and held it in 3 quarters.
  • Russell Investments Group's Tenaya Therapeutics position peaked at $78.3K in Q1 2023.
  • 95 funds tracked by Wall St. Rank held Tenaya Therapeutics as of Q3 2024.

Based on Russell Investments Group's 13F filing for Q3 2024, filed 13 Nov 2024.